Bioanalytical Testing Services Market Size Worth $ 9.22 Billion By 2032 | CAGR: 9.4%

The global bioanalytical testing services market size is expected to reach USD 9.22 billion by 2032, according to a new study by Polaris Market Research. The report “Bioanalytical Testing Services Market Share, Size, Trends, Industry Analysis Report: By Molecule, By Test, By Workflow, By Application, By End-Use, and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) – Market Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

There is a rising demand for bioanalytical testing services globally to ensure patient outcome, safety, and efficacy, which has led to the development of a lab-on-a-chip (LOC) technology that combines several laboratory operations onto a portable platform. They provide great sensitivity, mobility, and automation for testing, enabling complicated analyses with low sample and reagent use.

The field of in vitro diagnostics is currently experiencing a revolution due to the development of "lab-on-a-chip" micro-total analysis systems. These systems combine multiple laboratory operations into a single compact device, providing faster, more accurate, and more affordable testing capabilities for advanced and next-generation operational platforms.

The tiny chips, about the size of a credit card, function as fluidic integrated circuits. They allow liquid samples to pass through microchannels carved into the devices to mix and separate fluids, facilitate chemical reactions, and analyze materials. Lab-on-a-chip technology is used in various biological and chemical activities such as environmental monitoring and DNA sequencing.

In 2023, the bioengineering department at the University of Pennsylvania created a new, more reliable, affordable, and user-friendly lab-on-a-chip device with high resolution and speed. This device incorporates hybrid integrated and microfluidic circuit chip generations with three specific areas of application: high-throughput integrated large-scale microelectrode arrays for cell multimodal and stimulation sensing across a broad field of view, and high-speed biosensors for temporal resolution molecular analysis.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/bioanalytical-testing-services-market/request-for-sample

In recent years, the incorporation of biosensors into the bioanalytical testing equipment has made it easier to find new targets, screen drug candidates quickly, and evaluate the safety and efficacy of medications. Bioanalytical sensors foster the advancement of sensor technologies for use in biomedical applications, namely in the detection and quantification of therapeutically relevant analytes in complicated matrices. They are potent analytical tools that monitor label-free, real-time bimolecular interactions such as optical, chemical, electrochemical, and physical (mechanical, gravimetric, thermal, etc.) perturbations of a sample that can serve as the basis for detection.

Bioanalytical Testing Services Market Report Highlights

• The bioavailability segment dominated the bioanalytical testing services market due to the significant need for studies on the bioavailability of novel medications after administration.
• The sample analysis segment accounted for the largest market share owing to the phases of medication development and marketing, sample analysis.
• The sample preparation segment is expected to grow on account of the degree of selectivity, speed, convenience, and extraction phase configurations.
• North America dominated the market, largely due to the rising R&D investments made by biotechnology and pharmaceutical companies in new drug development.
• The global key market players include Covance, Inc., Charles River Laboratories International, Intertek Group Plc., ICON Plc., IQVIA, Labcorp (Toxikon), SGS SA, Pace Analytical Services LLC., Syneos Health, Thermo Fisher Scientific Inc., etc.

Polaris Market Research has segmented the bioanalytical testing services market report based on molecule type, test type, workflow, application, end-use, and region:

Bioanalytical Testing Services, Molecule Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Small Molecule
• Large Molecule
  • LC-MS Studies
  • Immunoassays
  • PK
  • ADA
  • Others

• Others

Bioanalytical Testing Services, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

• ADME
  • In-Vivo
  • In-Vitro

• PK
• PD
• Bioavailability
• Bioequivalence
• Others

Bioanalytical Testing Services, Workflow Outlook (Revenue - USD Billion, 2019 - 2032)

• Sample Analysis
  • Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance

• Sample Preparation
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
  • Others

• Others

Bioanalytical Testing Services, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Others

Bioanalytical Testing Services, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

• Pharma & BioPharma Companies
• CDMO
• CRO

Bioanalytical Testing Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

• Asia-Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Australia
• Malaysia
• Rest of Asia-Pacific

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

• Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

Bioanalytical Testing Services Report Scope: